.png?height=2000&name=nc_material%20(3).png)
This poster presents Ncardia’s iPSC-derived 3D cardiac microtissue platform, designed for scalable and automated high-throughput screening while maintaining physiological relevance and functional robustness over time.
Download it now for a closer look at:
How fully automated workflows enable the formation, maintenance, and functional analysis of 3D cardiac microtissues at screening scale
Functional validation data showing reproducible pharmacological responses, including chronotropic and inotropic effects, across large compound screens
Application of the Heart in a Box platform in ischemia–reperfusion and inherited arrhythmia disease models, supporting both safety and discovery use cases
Why integrating 3D cardiac microtissues into HTS pipelines improves translational relevance without compromising throughput or operational efficiency
Whether enabling large-scale compound screening or supporting disease-specific cardiac models, Ncardia’s Heart in a Box platform provides a reproducible, automated foundation for human-relevant cardiovascular screening at scale.